BioWorld - Saturday, November 23, 2024

BioWorld Insider Podcast

One-on-one with medical innovators

Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us each week for a new conversation.
Mike Ward and Karen Carey headshots

The struggle is real: The first half of 2023 was an uphill climb

Play
Listen
Duration: 25:46
08-16-2023

Guests Karen Carey, BioWorld’s managing editor, and Mike Ward, Clarivate’s global head of Life Sciences and Healthcare Thought Leadership, discuss the deals, financing and M&A landscape for the first half of 2023 and how U.K. biopharmas are faring post Brexit.

Download transcript

Download episode
Serebrov-and-Newcomer-podcast-7-20.jpg

The biosimilars challenge to Humira revs up

Play
Listen
Duration: 17:05
07-20-2023

Guests BioWorld Regulatory Editor Mari Serebrov and Tom Newcomer, Samsung Bioepis vice president and head of U.S. market access, discuss the launch of biosimilars that are taking on a blockbuster. 

Download transcript

Download episode
Brad-Holden,-CEO,--Resilient-Lifescience-podcast.jpg

Preventing opioid overdoses with a smart patch

You Must Login to Listen
Duration: 23:19
06-04-2023

Brad Holden, CEO of Resilient Lifescience, explains how the device works for overdoses as well as other potential applications for this new technology.

Download transcript

Download episode
Tim Shannon, general partner, Canaan podcast.jpg

Better times ahead for the biopharma sector? Could be, the new numbers say

Play
Listen
Duration: 27:59
04-21-2023

Karen Carey, BioWorld’s managing editor and senior data analyst, and Tim Shannon, a general partner at Canaan, break down the numbers from first quarter of 2023.

Download transcript

Download episode
Tamra Sami, staff writer, BioWorld

Radiopharmaceuticals: The next big disrupter?

You Must Login to Listen
Duration: 13:56
04-04-2023

BioWorld Staff Writer Tamra Sami talks about the science behind radiopharmaceuticals, the supply chain vulnerabilities, the regulatory landscape, the patient journey and therapies in the pipeline.

Download transcript

Download episode
James Peyer, CEO, Cambrian

Cambrian carves out a new niche as it works to keep people from getting sick

Play
Listen
Duration: 28:03
02-21-2023

James Peyer, the CEO of Cambrian Biopharma Inc., talks about anti-aging therapies, a business model that fits the new field of geroscience.

Download transcript

Download episode
Anette-Breindl,-BioWorld-senior-science-editor_hero.png

Rethinking obesity: Fitness may be more directly linked to health than weight

You Must Login to Listen
Duration: 21:20
01-30-2023

BioWorld Science Managing Editor Anette Breindl discusses her new analysis of multiple studies related to weight loss, metabolic health and fitness that in many ways go against mainstream theories about obesity.

Download transcript

Download episode
More Multimedia